Overview of Vitiligo Research July - September 2013
This is a VR Foundation’s regular review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from July 2013 till September 2013. Abstracts of papers were retrieved from the PubMed database using the search term “vitiligo” with a filter set up to retrieve records with creation date between July 01, 2013 and September 30, 2013. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Forty seven records have been selected for inclusion into this quarterly overview.
- Broad-band UVA phototherapy reported to be superior over narrow-band UVB treatment
- Foam formulation of clobetasol propionate may provide additional benefits in vitiligo treatment
- Additional evidence of regulatory T-cell role in vitiligo provided
- Sunscreen cream with bandpass centered at 311 nm has been described as a novel anti-vitiligo weapon
- Lesional keratinocytes might be deficient in NB-UVB response thus contributing to failure of phototherapy in repigmentation
- Every eighth patients treated with oral mini-pulse dexamethasone therapy to stop vitiligo progression will relapse at average of about 2.5 years after successful treatment
- Rituximab, anti-CD20 recombinant monoclonal antibody, may be efficient in vitiligo treatment
Full report is available for download in pdf
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
NY Vitiligo Community Meeting in September
Our next meeting will be on Thursday, September 21st, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Av...21 September 2017 19:00, 11th floor of NYU's Ambulatory Car...
Vitiligo Advocacy Day at the US Capitol
Save-the-Date for the much anticipated Vitiligo Advocacy Day at the United States Capitol this fall. As many of you know, the Advocacy Committee of the Global Vitilig...04 October 2017 10:00, Washington, DC
Pyrostegia venusta as a folk medicine for vitiligo?
Pyrostegia venusta is a neotropical evergreen vine widely spread in Brazil throughout fields, at the coast, edge of the woods and along roadsides (see photo below). Po...
Why there is no drug for vitiligo yet?
Despite the dearth of medications available to treat psoriasis - a disease with similar prevalence numbers and impact on quality of life - vitiligo has no known cure o...
Is there a traditional medicine to treat vitiligo?
During the last decades, new methods of therapeutic research, ethno-botany and ethno-pharmacology and even archeo-pharmacology (PubMed), have been used extensively to ...
How to get insurance coverage for vitiligo treatments?
Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantia...